Insider · CIK 0001733387

Nandabalan Krishnan

Reports to the SEC for 1 company · BRANFORD, CT

sec.gov

Transactions

Companies

Filings

CIK

0001733387

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-04-06	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+60K sh	$0.41	+$24.6K	60,000
2023-04-06	BTAIBioXcel Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−60K sh	$17.32	−$1.04M	0
2023-04-06	BTAIBioXcel Therapeutics, Inc. · Stock OptionsM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−60K sh	—	—	294,000
2023-01-05	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+25.9K sh	$0.41	+$10.6K	25,889
2023-01-05	BTAIBioXcel Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−25.1K sh	$22.32	−$560K	800
2023-01-05	BTAIBioXcel Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−800 sh	$22.93	−$18.3K	0
2023-01-05	BTAIBioXcel Therapeutics, Inc. · Stock OptionsM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−25.9K sh	—	—	354,000
2023-01-04	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+34.1K sh	$0.41	+$14K	34,111
2023-01-04	BTAIBioXcel Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−24.3K sh	$21.59	−$524K	9,821
2023-01-04	BTAIBioXcel Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−9,821 sh	$22.21	−$218K	0
2023-01-04	BTAIBioXcel Therapeutics, Inc. · Stock OptionsM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−34.1K sh	—	—	379,889
2022-11-15	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−146K sh	—	—	8,546,750
2022-11-15	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−291K sh	—	—	8,546,750
2022-11-15	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	+291K sh	—	—	8,546,750
2022-11-11	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+32.6K sh	$0.41	+$13.3K	32,550
2022-11-11	BTAIBioXcel Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−32.6K sh	$15.00	−$488K	0
2022-11-11	BTAIBioXcel Therapeutics, Inc. · Stock OptionsM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−32.6K sh	—	—	414,000
2022-11-10	BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+27.5K sh	$0.41	+$11.3K	27,450
2022-11-10	BTAIBioXcel Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−27.5K sh	$15.00	−$412K	0
2022-11-10	BTAIBioXcel Therapeutics, Inc. · Stock OptionsM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−27.5K sh	—	—	446,550
2021-06-25	BTAIBioXcel Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−473K sh	$30.83	−$14.6M	8,546,750
2021-04-06	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−103K sh	—	—	8,546,750
2021-04-06	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−131K sh	—	—	8,546,750
2021-04-06	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	+131K sh	—	—	8,546,750
2021-04-06	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−103K sh	—	—	8,546,750
2020-12-01	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−185K sh	—	—	9,020,000
2020-12-01	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−185K sh	—	—	9,020,000
2020-07-24	BTAIBioXcel Therapeutics, Inc.J Other	Director, 10% Owner	JOther	−160K sh	$60.76	−$9.72M	9,020,000
2020-07-24	BTAIBioXcel Therapeutics, Inc.J Other	Director, 10% Owner	JOther	+80K sh	$60.76	+$4.86M	80,000
2020-07-24	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−80K sh	—	—	0
2020-02-24	BTAIBioXcel Therapeutics, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−300K sh	$30.08	−$9.02M	9,180,000
2020-01-02	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+15K sh	—	—	15,000
2019-04-01	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	−1,000 sh	—	—	0
2019-04-01	BTAIBioXcel Therapeutics, Inc.G Gift	Director, 10% Owner	GGift	+1,000 sh	—	—	1,000
2018-11-29	BTAIBioXcel Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+1,000 sh	$4.92	+$4,915	1,000

Recent filings

Accepted (ET)
Apr 104
Nandabalan Krishnan0001104659-23-043694
SEC(opens sec.gov)
Feb 145
Nandabalan Krishnan0001104659-23-021791
SEC(opens sec.gov)
Jan 64
Nandabalan Krishnan0001104659-23-001945
SEC(opens sec.gov)
Nov 144
Nandabalan Krishnan0001104659-22-118836
SEC(opens sec.gov)

Companies

BioXcel Therapeutics, Inc.Director, 10% OwnerBTAI

Address

C/O BIOXCEL THERAPEUTICS, INC. 780 EAST MAIN STREET

BRANFORD, CT, 06405